High-dose versus Standard-dose Daunorubicin in Induction Chemotherapy for Acute Myeloid Leukemia: A Meta-Analysis

High-dose versus Standard-dose Daunorubicin in Induction Chemotherapy for Acute Myeloid Leukemia: A Meta-Analysis

Objective: This systematic review and meta-analysis aimed to compare the efficacy and safety of high-dose versus standard-dose daunorubicin in induction therapy for adult acute myeloid leukemia (AML), focusing on complete remission (CR), overall survival (OS), and event-free survival (EFS). Metho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bibi Kulsoom, Muhammad Nadeem, Hafiza Touseef Sayyar
Format:	Article
Language:	English
Published:	University of Lahore 2025-06-01
Series:	Journal of University College of Medicine and Dentistry
Subjects:	Acute Myeloid Leukemia Daunorubicin Event-Free Survival Complete Remission Meta-analysis Overall Survival
Online Access:	https://journals.uol.edu.pk/jucmd/article/view/3972
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
by: Fei Xin, et al.
Published: (2024-12-01)

The efficacy of bortezomib during induction therapy in patients with high-risk acute lymphoblastic leukemia
by: Camila Terreros-Palacios, et al.
Published: (2025-07-01)

The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome (CPX‐351) in Acute Myeloid Leukemia Patients: A Systematic Review
by: Abdulwahab M. Alzahrani, et al.
Published: (2025-05-01)

The demographic characteristics and prognosis of acute myeloid leukemia with t(3;3)/inv(3) in the united states: a SEER-based study
by: Xianfeng Ouyang, et al.
Published: (2025-04-01)

6-month survival of patients with acute myeloid leukemia who received modified chemotherapy at Wahidin Sudirohusodo Hospital
by: Edwinda D. Ratu, et al.
Published: (2024-09-01)

DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA
by: Juan Eduardo Megias-Vericat, et al.
Published: (2019-02-01)

Outcome Result of Acute Myeloid Leukemia Undergoing Treatment in Semi-Isolation Chemotherapy Ward
by: Cosphiadi Irawan, et al.
Published: (2022-09-01)

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia
by: Ashraf Zeidan Abdalla, et al.
Published: (2025-05-01)

Clinical profile of acute myeloid leukemia in North India and utility of nontransplant measures in its management
by: Nadeem Shoket, et al.
Published: (2019-01-01)

Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?
by: Satish Maharaj, et al.
Published: (2024-10-01)

Spontaneous remission of acute myeloid leukemia in children. Case series and literature review
by: V. V. Klyukhin, et al.
Published: (2024-12-01)

Modern strategies in therapy of elderly patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients: a systematic review and meta-analysis
by: Yun Liu, et al.
Published: (2025-05-01)

HSPG2 could promote normal haematopoiesis in acute myeloid leukaemia patients after complete remission by repairing bone marrow endothelial progenitor cells
by: Chen‐Yuan Li, et al.
Published: (2025-02-01)

Efficacy and safety of mitoxantrone hydrochloride liposome-containing regimens in treating refractory/relapsed acute myeloid leukemia
by: Ni Lu, et al.
Published: (2025-05-01)

Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran
by: Mahshid Heidary Sadegh, et al.
Published: (2025-01-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Prognosis of RUNX1-RUNX1T1 Rearrangement in Newly Diagnosed Acute Myeloid Leukemia Patients
by: Halima Babar, et al.
Published: (2023-10-01)

Genetic profile of ASXL1 gene in risk assessment in acute myeloid leukemia
by: Salem Ahmed Bamusa, et al.
Published: (2025-07-01)

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia
by: E. V. Usikova, et al.
Published: (2023-01-01)

The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience
by: Urošević Ivana, et al.
Published: (2021-01-01)

Long-Term Safety and Efficacy of Imatinib in Chronic Myeloid Leukemia: Real-World Evidence from a Single-Center Study
by: İsmail Can Kendir, et al.
Published: (2025-06-01)

Demographic and clinical characteristics of chronic myeloid leukemia patients: A study on confined populations of Southern India
by: Manjula Gorre, et al.
Published: (2019-01-01)

Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Complexation reaction with Sm(III): a facile spectrophotometric quantification of daunorubicin in pharmaceutical preparation and biological fluids
by: Basima A. A. Saleem
Published: (2025-08-01)

Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia
by: Yuyang Wang, et al.
Published: (2025-07-01)

Exploring the Immunomodulatory Effects of Liposomal Daunorubicin on Jurkat Cells: A Study of Apoptosis and Gene Expression in Co-Cultured MDA-MB-231 Cells
by: Malik Kareem Shanan, et al.
Published: (2025-07-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

Hypomethylation of GCNT2 isoform A correlates with transcriptional expression and is associated with poor survival in acute myeloid leukemia
by: De-hong Wu, et al.
Published: (2025-02-01)

Eligibility for treatment-free remission among chronic myeloid leukemia patients in Iraqi Kurdistan region
by: Haydar Hasan Darwes, et al.
Published: (2025-01-01)

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia
by: N. P. Kirsanova, et al.
Published: (2022-11-01)

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India
by: Thejeswar Nakka, et al.
Published: (2025-06-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
by: Mingyang Wang, et al.
Published: (2025-01-01)

Influence of Perfluorodecalin on Growth of Actinomycetes and Intensification of Streptomycin and Daunorubicin Production by the Genus Streptomyces Kind Bacteria in Submerged Culture
by: V. M. Bakulin, et al.
Published: (2020-05-01)

The Age Standardized Remission Rate of Acute Myeloid Leukemia in Adults
by: Sana Hashmat, et al.
Published: (2024-12-01)

Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review
by: Lauro Fabián Amador-Medina, et al.
Published: (2024-12-01)

Utilization of machine learning to predict antibiotic resistant event outcomes in acute myeloid leukemia patients undergoing induction chemotherapy
by: Stephanie McMahon, et al.
Published: (2025-08-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)